Global Burden of Disease Brain Summit
Tuesday, 27 November 2018
8.00am – 6.00pm
Auckland University of Technology (AUT)
‘The world’s leading minds with gather for the Global Burden of Disease Brain Summit at AUT’
International researchers, health professionals and policymakers will gather at Auckland University of Technology (AUT) for the Global Burden of Disease Brain Summit. The one-day summit brings together the world’s leading minds and best available research on the global burden of neurological disorders, with those most committed to improving public health outcomes.
As the leading cause of disability and second cause of death, neurological disorders represent a huge global health problem. One-in-three people now suffer from a neurological disorder worldwide. In the past 15 years, the people affected has increased from 20 percent to more than 30 percent.
Professor Valery Feigin, Director of the National Institute for Stroke and Applied Neurosciences at AUT, says: “We need worldwide cooperation in the research, treatment and prevention of neurological disorders, which is grossly underfunded. Neurological care within the public health system needs to be strengthened, and effective primary prevention is essential to help curb this global health crisis”.
The Global Burden of Disease Brain Summit is a collaboration between AUT, The Lancet Neurology and the Global Burden of Disease (GBD) study which is coordinated by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
The Lancet Neurology will release a special collection of articles on the global burden of neurological disorders before an international audience at the event. The articles present expert analysis of the latest evidence from the GBD study. Collected by a consortium of more than 3,000 researchers in 140 countries, GBD data provides a comprehensive picture of the incidence, prevalence, disability and mortality of neurological disorders, as well as more than 300 other diseases, worldwide.
The event programme features – Professor Valery Feigin (AUT), Professor Chris Murray (Director, IHME), Professor Theo Vos (GBD study), Dr Elena Becker-Barroso (Editor-in-Chief, The Lancet Neurology), Professor Kathryn McPherson (Chief Executive, Health Research Council) and experts in neurological disorders from the U.S, U.K, Belgium, Austria, Italy, Egypt, Nigeria, Sri Lanka, China, Korea, Australia and New Zealand.
Attendance at the Global Burden of Disease Brain Summit is by invitation only.
The event will be live-streamed at aut.ac/AUTbrainsummitLIVE
Join the conversation at #AUTbrainsummit